EVH Evolent Health, Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$5.85

Period return

+2.01 (+52.34%)

Volume

1.0M

2026-07-21O $5.89 H $5.99 L $5.72 C $5.85MA5 $5.83MA20 $5.63MA60 $4.6MA120 $3.71

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 08. 06.Highin 16 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 16.LowBUY2 months ago
Citigroup: Buy
US analyst rating / recommendation change.
2026. 05. 15.High2 months ago
13F 기관 보유 변화 — TWO SIGMA INVESTMENTS, LP
신규 편입 · 포트폴리오 비중 0.00%
2026. 05. 13.LowBUY2 months ago
Canaccord Genuity: Buy
US analyst rating / recommendation change.
2026. 05. 08.LowBUY3 months ago
Needham: Buy
US analyst rating / recommendation change.
2026. 03. 03.LowBUY5 months ago
Oppenheimer: Outperform
US analyst rating / recommendation change.
2026. 02. 27.LowBUY5 months ago
Citigroup: Buy
US analyst rating / recommendation change.
2026. 02. 27.LowBUY5 months ago
UBS: Buy
US analyst rating / recommendation change.
2026. 02. 26.LowBUY5 months ago
Truist Securities: Buy
US analyst rating / recommendation change.
2026. 02. 26.LowBUY5 months ago
Needham: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $5.75 · 14 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Sector: Healthcare
Industry: Health Information Services
HQ: Arlington, VA, United States
Fiscal year end: —
Employees: 4,200
IPO date: —

View details →

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 08. 06.	After market close (AMC)	$-0.02	—	—	$599.07M	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$-0.63	—	—	$483.65M	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$-0.55	—	—	$1.91B	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$-0.28	—	—	$1.29B	Reported

#	Institution	Mandate	Shares	Value	Weight	Change	Position
1	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	1,537,524	$6.15M	0.01%	—	New position
2	Point72 Asset Management, L.P.	Point72 Asset Management, L.P.	564,954	$2.26M	0.00%	—	New position
3	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	871,493	$1.99M	0.00%	—	New position

Evolent Health, Inc.

Price chart

Recent event timeline

Recent earnings

Research actions

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 16.	Citigroup	—	Maintain	Buy → Buy	—	Citigroup: Buy
2026. 05. 13.	Canaccord Genuity	—	Maintain	Buy → Buy	—	Canaccord Genuity: Buy
2026. 05. 08.	Needham	—	Maintain	Buy → Buy	—	Needham: Buy
2026. 03. 03.	Oppenheimer	—	Maintain	Outperform → Outperform	—	Oppenheimer: Outperform
2026. 02. 27.	Citigroup	—	Maintain	Buy → Buy	—	Citigroup: Buy
2026. 02. 27.	UBS	—	Maintain	Buy → Buy	—	UBS: Buy